THE CHANGES OF CYTOKINE LEVEL IN THE BLOOD OF COPD PATIENTS AFTER ALLOGENEIC UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION WITH PLALETE RICH PLASMA

Lê Thị Bích Phượng1,, Đỗ Quyết2, Lê Văn Đông3, Cấn Văn Mão4, Nguyễn Lĩnh Toàn4, Nguyễn Viết Nhung5, Đồng Khắc Hưng2, Đỗ Minh Trung2
1 Van Hanh General Hospital
2 Institute of BioMedicine and Pharmacy, Vietnam Military Medical University
3 Military Institute of Preventive Medicine
4 Vietnam Military Medical University
5 National Lung Hospital

Main Article Content

Abstract

Objective: To study the changes of cytokine level in the blood of COPD patients after allogeneic umbilical cord-derived mesenchymal stem cell (UC-MSC) transplantation with platelets rich protein. Subjects and methods: Plasma of 10 COPD patients treated by internal medicine and 18 ones by UC-MSC transtplantation were collected at the National Lung Hospital and Van Hanh Hospital at the time points before transplantation (0) and after 1, 3, 7 and 12 months of transplantation. The quantitative concentrations of cytokines were measured by ELISA. Results: Before the treatment, the cytokine levels of the control group were not significantly higher than that of the treated group (p>0,05). After the treatment, in the control group, IL-8, IL-1β, IL-6, IFN-γ and IL-10 levels tended to increase, while TNF-α and VEGF decreased (p>0,05). In contrast, the cytokine levels of the treated group decreased; IL-10 and VEGF expression increased (p<0,05). Conclusion: The inflammatory cytokine levels of UC-MSC transplantation with platelets rich protein patients decreased and VEGF increased after treatment, which may limit the inflammation and enhanced the tissue regeneration.

Article Details

References

1. Global initiative for Chronic obstructive lung disease (2017), "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2017 report".
2. Barnes P.J. (2009), "The cytokine network in chronic obstructive pulmonary disease.", Am J Respir Cell Mol Biol,41(6), pp. 631-638.
3. Guan X., Song L., Han F., et al (2013), "Mesenchymal stem cells protect cigarette smoke‐damaged lung and pulmonary function partly via VEGF–VEGF receptors", J Cell Biochem, 114(2), pp. 323-335.
4. Dao Ngoc Bang, Dong Khac Hung, Ta Ba Thang, et al. (2017), "Results of one-way bronchial value placement in treatment of emphysema", J Mil Pharmaco-Medicine, 7, pp. 78-88.
5. Chen J., Li X. and Huang C.L. et al (2020), "Change of Serum Inflammatory Cytokines Levels in Patients With Chronic Obstructive Pulmonary Disease, Pneumonia and Lung Cancer", Technol Cancer Res Treat, 19.
6. Wei B. and Sheng Li C. (2018), "Changes in Th1/Th2-producing cytokines during acute exacerbation chronic obstructive pulmonary disease", J Int Med Res, 46(9), pp. 3890-3902.
7. Yu Y., Zhao L., Xie Y., et al (2020), "Th1/th17 cytokine profiles are associated with disease severity and exacerbation frequency in copd patients", Int J COPD, 15, pp. 1287-1299.
8. Silva B.S.A., Lira F.S., Ramos D., et al (2018), "Severity of COPD and its relationship with IL-10", Cytokine, 106(95-100).
9. Huh J.W., Kim S.Y., J.H. L. (2011), "Huh J.W., Kim S.Y., Lee J.H., et al. (2011). Bone marrow cells repair cigarette smoke-induced emphysema in rats", Am J Physiol - Lung Cell Mol Physiol, 301(3).
10. Voelkel N.F., Vandivier R.W., R.M. T. (2006), "Vascular endothelial growth factor in the lung", Am J Physiol - Lung Cell Mol Physiol, 290(2).